Topic

California

A collection of 46 issues

Coding That Helps Get Oxervate (cenegermin) Approved by UnitedHealthcare in California: ICD-10, HCPCS, and NDC Guide

Answer Box: Getting Oxervate Covered by UnitedHealthcare in California Oxervate (cenegermin) requires prior authorization from UnitedHealthcare with specific coding requirements. Use ICD-10 codes H16.231-H16.233 for stage 2/3 neurotrophic keratitis, HCPCS code J3590, and NDC 71923-019-01. Submit through OptumRx with documented artificial tear failure and ophthalmologist prescription. If
6 min read

Renewing Hemgenix Coverage with Blue Cross Blue Shield in California: Annual Requirements and Timeline

Answer Box: Blue Shield of California requires annual reauthorization for Hemgenix (etranacogene dezaparvovec) gene therapy. Start renewal 60-90 days before your authorization expires. Submit updated clinical documentation showing ongoing eligibility, Factor IX levels, bleeding episodes, liver function tests, and provider attestation through Blue Shield's AuthAccel portal or designated
5 min read

Do You Qualify for Kuvan (Sapropterin) Coverage by Aetna CVS Health in California? Decision Tree & Next Steps

Answer Box: Your Path to Kuvan Coverage Kuvan (sapropterin) is covered by Aetna CVS Health as a specialty medication with prior authorization required. Most PKU patients qualify if they have confirmed diagnosis, demonstrate BH4-responsiveness (≥20% phenylalanine reduction), and maintain dietary management under specialist care. Fastest approval path: 1. Your metabolic
5 min read

Work With Your Doctor to Get Retevmo (selpercatinib) Covered by Humana in California: Templates, Timelines & Appeal Scripts

Quick Answer: Getting Retevmo (selpercatinib) Covered by Humana in California Humana Medicare Advantage requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive cancers. Your oncologist must submit documentation proving RET alteration status through Evolent's portal or by calling 844-926-4528. If denied, you have 65 days to appeal and
6 min read

If Zanzalintinib (XL092) Isn't Approved by UnitedHealthcare in California: Formulary Alternatives & Exception Paths

Answer Box: Getting Zanzalintinib (XL092) Covered by UnitedHealthcare in California Zanzalintinib (XL092) is investigational and typically not covered by UnitedHealthcare outside clinical trials. Your fastest paths: 1) Request compassionate use through Exelixis (drug provided free), 2) Try covered multi-target TKI alternatives like cabozantinib or lenvatinib with prior authorization, or 3)
5 min read

How to Get Xywav (Ca/Mg/K/Na oxybates) Covered by Cigna in California: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Xywav Covered by Cigna in California Cigna requires prior authorization for Xywav with strict criteria: confirmed narcolepsy/idiopathic hypersomnia diagnosis, sleep studies, specialist prescription, failed dextroamphetamine trial, and REMS enrollment. First step: Have your sleep specialist submit PA request with complete documentation to Cigna/Express Scripts. If
6 min read